Critically, in-depth in vitro studies that assess whether there is a direct link between changes to resting myosin conformation and molecular mechanisms that are impaired in the skeletal muscle of individuals with type 2 diabetes, such as insulin resistance, are required in order to confirm that such a modality would effectively treat type 2 diabetes. This evidence concerns the gene MYH14 and type 2 diabetes mellitus.